MODERATE PLAQUE PSORIASIS
Clinical trials for MODERATE PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Head-to-Head showdown: injection vs. pill for psoriasis relief
Disease control OngoingThis study directly compares two already-approved medications for adults with moderate plaque psoriasis. Participants will receive either an injection every 12 weeks or take a daily pill for up to 44 weeks. The goal is to see which treatment is more effective at clearing skin and…
Matched conditions: MODERATE PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 04, 2026 00:05 UTC
-
New psoriasis drug study aims to clear skin and restore quality of life
Disease control OngoingThis study observes how well the approved medication risankizumab works for people recently diagnosed with moderate plaque psoriasis in real-world Greek clinics. About 250 participants who haven't tried advanced treatments will be followed for two years while taking risankizumab …
Matched conditions: MODERATE PLAQUE PSORIASIS
Sponsor: AbbVie • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC